Skip to search formSkip to main contentSkip to account menu

Recombinant EphB4-HSA Fusion Protein

Known as: sEphB4-HSA 
A recombinant fusion protein composed of the full-length extracellular domain (soluble) of human receptor tyrosine kinase ephrin type-B receptor 4… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
TPS274Background: The EphB4/EphrinB2 pathway is a promising therapeutic target for patients with mCRPC. EphB4 expression is… 
2018
2018
285Background: EphrinB4, a receptor kinase, is associated with stage and survival in epithelial cancers. sEphB4 is a fusion… 
2016
2016
Members of the Eph family of receptor tyrosine kinases have been implicated in a wide array of human cancers. The EphB4 receptor… 
2014
2014
Effective treatment of transitional cell carcinoma (TCC) of the bladder requires early diagnosis. Identifying novel molecular… 
2013
2013
BackgroundMalignant pleural mesothelioma (MPM) often develops decades following exposure to asbestos. Current best therapy… 
2012
2012
The use of albumin fusion proteins as therapeutic drug candidates is an attractive approach to design novel biopharmaceuticals… 
Highly Cited
2009
Highly Cited
2009
Kaposi sarcoma (KS) is associated with human herpesvirus (HHV)-8 and is dependent on the induction of vascular endothelial growth… 
2009
2009
Immunotherapy of cancer offers great promise, however translation into human studies has yielded relatively poor results to date…